TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Porcine Epidemic Diarrhea Vaccines Market, Global Outlook and Forecast 2024-2030

Porcine Epidemic Diarrhea Vaccines Market, Global Outlook and Forecast 2024-2030

  • Category:Life Sciences
  • Published on : 21 March 2024
  • Pages :108
  • Formats:
  • Report Code:SMR-7925629
OfferClick for best price

Best Price: $2600

Porcine Epidemic Diarrhea Vaccines Market Size, Share 2024


Market size in 2023 US$ 145.2 million
Forecast Market size by 2030 US$ 235.6 million
Growth Rate CAGR of 7.3% Number of Pages 108 Pages

The global Porcine Epidemic Diarrhea Vaccines market was valued at US$ 145.2 million in 2023 and is projected to reach US$ 235.6 million by 2030, at a CAGR of 7.3% during the forecast period.

This research report provides a comprehensive analysis of the Porcine Epidemic Diarrhea Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Porcine Epidemic Diarrhea Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Porcine Epidemic Diarrhea Vaccines, challenges faced by the industry, and potential opportunities for market players.

The global Porcine Epidemic Diarrhea Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Porcine Epidemic Diarrhea Vaccines market presents opportunities for various stakeholders, including Piglets, Adults Pigs. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Porcine Epidemic Diarrhea Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.

Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.

Key Features:

The research report on the Porcine Epidemic Diarrhea Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.

Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Porcine Epidemic Diarrhea Vaccines market.

Market Overview: The report provides a comprehensive overview of the Porcine Epidemic Diarrhea Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Live Vaccines, Killed Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.

Market Dynamics: The report analyses the market dynamics driving the growth and development of the Porcine Epidemic Diarrhea Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Porcine Epidemic Diarrhea Vaccines market's trajectory.

Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Porcine Epidemic Diarrhea Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.

Market Segmentation and Forecast: The report segment the Porcine Epidemic Diarrhea Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.

Technological Trends: The report should highlight the key technological trends shaping the Porcine Epidemic Diarrhea Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.

Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Porcine Epidemic Diarrhea Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.

Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Porcine Epidemic Diarrhea Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.

Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Porcine Epidemic Diarrhea Vaccines market.

Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.

Market Segmentation

  • Porcine Epidemic Diarrhea Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type

  • Live Vaccines
  • Killed Vaccines

Market segment by Application

  • Piglets
  • Adults Pigs

Global Porcine Epidemic Diarrhea Vaccines Market Segment Percentages, By Region and Country, 2023 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Major players covered

  • CAVAC
  • Green Cross Veterinary Products
  • Harrisvaccines
  • Komipharm
  • Nisseiken
  • Qilu Animal Health
  • Zoetis

Outline of Major Chapters:

Chapter 1: Introduces the definition of Porcine Epidemic Diarrhea Vaccines, market overview.

Chapter 2: Global Porcine Epidemic Diarrhea Vaccines market size in revenue and volume.

Chapter 3: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Epidemic Diarrhea Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Porcine Epidemic Diarrhea Vaccines capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Porcine Epidemic Diarrhea Vaccines Market, Global Outlook and Forecast 2024-2030
Market size in 2023 US$ 145.2 million
Forecast Market size by 2030 US$ 235.6 million
Growth Rate CAGR of 7.3%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 108 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Porcine Epidemic Diarrhea Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porcine Epidemic Diarrhea Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porcine Epidemic Diarrhea Vaccines Overall Market Size
2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size: 2023 VS 2030
2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Porcine Epidemic Diarrhea Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Porcine Epidemic Diarrhea Vaccines Players in Global Market
3.2 Top Global Porcine Epidemic Diarrhea Vaccines Companies Ranked by Revenue
3.3 Global Porcine Epidemic Diarrhea Vaccines Revenue by Companies
3.4 Global Porcine Epidemic Diarrhea Vaccines Sales by Companies
3.5 Global Porcine Epidemic Diarrhea Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Porcine Epidemic Diarrhea Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Porcine Epidemic Diarrhea Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porcine Epidemic Diarrhea Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Porcine Epidemic Diarrhea Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Porcine Epidemic Diarrhea Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Porcine Epidemic Diarrhea Vaccines Market Size Markets, 2023 & 2030
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue & Forecasts
4.2.1 By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Porcine Epidemic Diarrhea Vaccines Sales & Forecasts
4.3.1 By Type - Global Porcine Epidemic Diarrhea Vaccines Sales, 2019-2024
4.3.2 By Type - Global Porcine Epidemic Diarrhea Vaccines Sales, 2025-2030
4.3.3 By Type - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Porcine Epidemic Diarrhea Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Porcine Epidemic Diarrhea Vaccines Market Size, 2023 & 2030
5.1.2 Piglets
5.1.3 Adults Pigs
5.2 By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue & Forecasts
5.2.1 By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Porcine Epidemic Diarrhea Vaccines Sales & Forecasts
5.3.1 By Application - Global Porcine Epidemic Diarrhea Vaccines Sales, 2019-2024
5.3.2 By Application - Global Porcine Epidemic Diarrhea Vaccines Sales, 2025-2030
5.3.3 By Application - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Porcine Epidemic Diarrhea Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Porcine Epidemic Diarrhea Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue & Forecasts
6.2.1 By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Porcine Epidemic Diarrhea Vaccines Sales & Forecasts
6.3.1 By Region - Global Porcine Epidemic Diarrhea Vaccines Sales, 2019-2024
6.3.2 By Region - Global Porcine Epidemic Diarrhea Vaccines Sales, 2025-2030
6.3.3 By Region - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Porcine Epidemic Diarrhea Vaccines Sales, 2019-2030
6.4.3 US Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.4.4 Canada Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.4.5 Mexico Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Porcine Epidemic Diarrhea Vaccines Sales, 2019-2030
6.5.3 Germany Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.4 France Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.5 U.K. Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.6 Italy Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.7 Russia Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.5.9 Benelux Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Porcine Epidemic Diarrhea Vaccines Sales, 2019-2030
6.6.3 China Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.6.4 Japan Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.6.5 South Korea Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.6.7 India Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Porcine Epidemic Diarrhea Vaccines Sales, 2019-2030
6.7.3 Brazil Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.7.4 Argentina Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales, 2019-2030
6.8.3 Turkey Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.8.4 Israel Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
6.8.6 UAE Porcine Epidemic Diarrhea Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 CAVAC
7.1.1 CAVAC Company Summary
7.1.2 CAVAC Business Overview
7.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 CAVAC Key News & Latest Developments
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Company Summary
7.2.2 Green Cross Veterinary Products Business Overview
7.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Green Cross Veterinary Products Key News & Latest Developments
7.3 Harrisvaccines
7.3.1 Harrisvaccines Company Summary
7.3.2 Harrisvaccines Business Overview
7.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Harrisvaccines Key News & Latest Developments
7.4 Komipharm
7.4.1 Komipharm Company Summary
7.4.2 Komipharm Business Overview
7.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 Komipharm Key News & Latest Developments
7.5 Nisseiken
7.5.1 Nisseiken Company Summary
7.5.2 Nisseiken Business Overview
7.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Nisseiken Key News & Latest Developments
7.6 Qilu Animal Health
7.6.1 Qilu Animal Health Company Summary
7.6.2 Qilu Animal Health Business Overview
7.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Qilu Animal Health Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Major Product Offerings
7.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Zoetis Key News & Latest Developments
8 Global Porcine Epidemic Diarrhea Vaccines Production Capacity, Analysis
8.1 Global Porcine Epidemic Diarrhea Vaccines Production Capacity, 2019-2030
8.2 Porcine Epidemic Diarrhea Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Porcine Epidemic Diarrhea Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porcine Epidemic Diarrhea Vaccines Supply Chain Analysis
10.1 Porcine Epidemic Diarrhea Vaccines Industry Value Chain
10.2 Porcine Epidemic Diarrhea Vaccines Upstream Market
10.3 Porcine Epidemic Diarrhea Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porcine Epidemic Diarrhea Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Porcine Epidemic Diarrhea Vaccines in Global Market
Table 2. Top Porcine Epidemic Diarrhea Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Porcine Epidemic Diarrhea Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Porcine Epidemic Diarrhea Vaccines Sales by Companies, (M Units), 2019-2024
Table 6. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Porcine Epidemic Diarrhea Vaccines Price (2019-2024) & (USD/K Unit)
Table 8. Global Manufacturers Porcine Epidemic Diarrhea Vaccines Product Type
Table 9. List of Global Tier 1 Porcine Epidemic Diarrhea Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porcine Epidemic Diarrhea Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2019-2024
Table 15. By Type - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2025-2030
Table 16. By Application ? Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2019-2024
Table 20. By Application - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2025-2030
Table 21. By Region ? Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2019-2024
Table 25. By Region - Global Porcine Epidemic Diarrhea Vaccines Sales (M Units), 2025-2030
Table 26. By Country - North America Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2019-2024
Table 29. By Country - North America Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2025-2030
Table 30. By Country - Europe Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2019-2024
Table 33. By Country - Europe Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2025-2030
Table 34. By Region - Asia Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2019-2024
Table 37. By Region - Asia Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2025-2030
Table 38. By Country - South America Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2019-2024
Table 41. By Country - South America Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2025-2030
Table 42. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2019-2024
Table 45. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales, (M Units), 2025-2030
Table 46. CAVAC Company Summary
Table 47. CAVAC Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 48. CAVAC Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 49. CAVAC Key News & Latest Developments
Table 50. Green Cross Veterinary Products Company Summary
Table 51. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 52. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 53. Green Cross Veterinary Products Key News & Latest Developments
Table 54. Harrisvaccines Company Summary
Table 55. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 56. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 57. Harrisvaccines Key News & Latest Developments
Table 58. Komipharm Company Summary
Table 59. Komipharm Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 60. Komipharm Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 61. Komipharm Key News & Latest Developments
Table 62. Nisseiken Company Summary
Table 63. Nisseiken Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 64. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 65. Nisseiken Key News & Latest Developments
Table 66. Qilu Animal Health Company Summary
Table 67. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 68. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 69. Qilu Animal Health Key News & Latest Developments
Table 70. Zoetis Company Summary
Table 71. Zoetis Porcine Epidemic Diarrhea Vaccines Product Offerings
Table 72. Zoetis Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 73. Zoetis Key News & Latest Developments
Table 74. Porcine Epidemic Diarrhea Vaccines Production Capacity (M Units) of Key Manufacturers in Global Market, 2022-2024 (M Units)
Table 75. Global Porcine Epidemic Diarrhea Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 76. Global Porcine Epidemic Diarrhea Vaccines Production by Region, 2019-2024 (M Units)
Table 77. Global Porcine Epidemic Diarrhea Vaccines Production by Region, 2025-2030 (M Units)
Table 78. Porcine Epidemic Diarrhea Vaccines Market Opportunities & Trends in Global Market
Table 79. Porcine Epidemic Diarrhea Vaccines Market Drivers in Global Market
Table 80. Porcine Epidemic Diarrhea Vaccines Market Restraints in Global Market
Table 81. Porcine Epidemic Diarrhea Vaccines Raw Materials
Table 82. Porcine Epidemic Diarrhea Vaccines Raw Materials Suppliers in Global Market
Table 83. Typical Porcine Epidemic Diarrhea Vaccines Downstream
Table 84. Porcine Epidemic Diarrhea Vaccines Downstream Clients in Global Market
Table 85. Porcine Epidemic Diarrhea Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Porcine Epidemic Diarrhea Vaccines Segment by Type in 2023
Figure 2. Porcine Epidemic Diarrhea Vaccines Segment by Application in 2023
Figure 3. Global Porcine Epidemic Diarrhea Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Porcine Epidemic Diarrhea Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Porcine Epidemic Diarrhea Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Porcine Epidemic Diarrhea Vaccines Sales in Global Market: 2019-2030 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Porcine Epidemic Diarrhea Vaccines Revenue in 2023
Figure 9. By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit), 2019-2030
Figure 13. By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit), 2019-2030
Figure 17. By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 23. US Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 37. China Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Porcine Epidemic Diarrhea Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Porcine Epidemic Diarrhea Vaccines Production Capacity (M Units), 2019-2030
Figure 53. The Percentage of Production Porcine Epidemic Diarrhea Vaccines by Region, 2023 VS 2030
Figure 54. Porcine Epidemic Diarrhea Vaccines Industry Value Chain
Figure 55. Marketing Channels

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount